Modern Chinese Medicine (HKG:1643) expects a net loss of not less than 13 million yuan for 2025, compared with a net profit of about 9.7 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.

The expected loss is due to the loss of certain distributors, reduced purchase orders, and the exclusion of some key products from the national medical insurance list, which weighed on sales.

The company said its annual results are expected to be published by the end of March.